Evidence map›Paper›PMID 34514710›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic.

Madeleine R Heldman, Olivia S Kates, Kassem Safa, Camille N Kotton, Sarah J Georgia, Julie M Steinbrink, Barbara D Alexander, Marion Hemmersbach-Miller, Emily A Blumberg, Ashrit Multani and 35 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 77 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient.Transplant infectious disease : an official journal of the Transplantation Society · 2024
    Article
  7. COVID-19 in organ donors: An organ procurement organization perspective.Transplant infectious disease : an official journal of the Transplantation Society · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaboration.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 2 countries.

Madeleine R HeldmanDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.ORCID 0000-0002-9424-1870
Olivia S KatesDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.ORCID 0000-0003-4381-0049
Kassem SafaMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-9283-7662
Camille N KottonMassachusetts General Hospital, Boston, Massachusetts.
Sarah J GeorgiaMassachusetts General Hospital, Boston, Massachusetts.
Julie M SteinbrinkDivision of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina.
Barbara D AlexanderDivision of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina.
Marion Hemmersbach-MillerSection of Infectious Diseases, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-6041-6815
Emily A BlumbergDepartment of Medicine, Division of Infectious Diseases, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-5193-6170
Ashrit MultaniDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Brandy HaydelRecanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Ricardo M La HozDivision of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-1560-3192
Lisset MoniUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Yesabeli CondorUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Sandra FloresUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Carlos G MunozUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Juan GuitierrezUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Esther I DiazUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Daniela DiazUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Rodrigo ViannaUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Giselle GuerraUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.ORCID 0000-0002-4098-4652
Matthias LoebeUniversity of Miami/Jackson Memorial Hospital, Miami, Florida.
Robert M RakitaDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.ORCID 0000-0001-8105-8455
Maricar MalinisSection of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0002-5720-9994
Marwan M AzarSection of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0001-5498-5042
Vagish HemmigeDivision of Infectious Disease, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
Margaret E McCortDivision of Infectious Disease, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
Zohra S ChaudhryTransplantation Infectious Diseases and Immunotherapy, Henry Ford Health System, Detroit, Michigan.ORCID 0000-0002-8733-2264
Pooja P SinghDivision of Nephrology, University of New Mexico, Albuquerque, New Mexico.
Kailey Hughes KramerTransplant Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania.
Arzu VeliogluDepartment of Internal Medicine, Division of Nephrology, School of Medicine, Marmara University, Istanbul, Turkey.ORCID 0000-0001-9750-7585
Julie M YabuDivision of Nephrology, Department of Medicine, University of California, Los Angeles, California.
Jose A MorillisDepartment of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio.
Sapna A MehtaNYU Langone Transplant Institute, New York, New York.ORCID 0000-0002-5588-905X
Sajal D TannaDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0003-2641-5004
Michael G IsonDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0003-3347-9671
Ariella C DerengeDepartment of Medicine, Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
David van DuinDivision of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0003-4784-3227
Adrienne MaximinINTEGRIS Health, Oklahoma City, Oklahoma.
Carlene GilbertBanner Health, Phoenix, Arizona.
Jason D GoldmanDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.ORCID 0000-0002-3825-6832
Erika D LeaseDivision of Pulmonology, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington.ORCID 0000-0002-1816-6733
Cynthia E FisherDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.
Ajit P LimayeDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.
UW COVID-19 SOT Study Team
University of Miami · USUniversity of Washington · USMassachusetts General Hospital · USAlbert Einstein College of Medicine · USDuke University · USNorthwestern University · USUniversity of California, Los Angeles · USYale University · USBanner Health · USBaylor College of Medicine · USCleveland Clinic · USHenry Ford Health System · USIcahn School of Medicine at Mount Sinai · USIntegris Health · USMarmara University · TRMiami Transplant Institute · USThe University of Texas Southwestern Medical Center · USThomas Jefferson University · USUniversity of New Mexico · USUniversity of North Carolina at Chapel Hill · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTGT32AI100851 · NIAID · DUKE UNIVERSITY · PI ALEXANDER, BARBARA D · 2013 to 2022
$1.8M
Respiratory Viral Determinants of Chronic Lung Allograft DysfunctionK23HL143050 · NHLBI · UNIVERSITY OF WASHINGTON · PI FISHER, CYNTHIA E · 2018 to 2022
$986k
National Institute of Allergy and Infectious Diseases T32AI118690NCATS NIH HHS UL1 TR001863NHLBI NIH HHS HL143050NHLBI NIH HHS K23 HL143050NIAID NIH HHS T32 AI100851
6 · The paper itself

Abstract

Mortality among patients hospitalized for COVID-19 has declined over the course of the pandemic. Mortality trends specifically in solid organ transplant recipients (SOTR) are unknown. Using data from a multicenter registry of SOTR hospitalized for COVID-19, we compared 28-day mortality between early 2020 (March 1, 2020-June 19, 2020) and late 2020 (June 20, 2020-December 31, 2020). Multivariable logistic regression was used to assess comorbidity-adjusted mortality. Time period of diagnosis was available for 1435/1616 (88.8%) SOTR and 971/1435 (67.7%) were hospitalized: 571/753 (75.8%) in early 2020 and 402/682 (58.9%) in late 2020 (p < .001). Crude 28-day mortality decreased between the early and late periods (112/571 [19.6%] vs. 55/402 [13.7%]) and remained lower in the late period even after adjusting for baseline comorbidities (aOR 0.67, 95% CI 0.46-0.98, p = .016). Between the early and late periods, the use of corticosteroids (≥6 mg dexamethasone/day) and remdesivir increased (62/571 [10.9%] vs. 243/402 [61.5%], p < .001 and 50/571 [8.8%] vs. 213/402 [52.2%], p < .001, respectively), and the use of hydroxychloroquine and IL-6/IL-6 receptor inhibitor decreased (329/571 [60.0%] vs. 4/492 [1.0%], p < .001 and 73/571 [12.8%] vs. 5/402 [1.2%], p < .001, respectively). Mortality among SOTR hospitalized for COVID-19 declined between early and late 2020, consistent with trends reported in the general population. The mechanism(s) underlying improved survival require further study.

Indexed as

COVID-19Organ TransplantationHumansPandemicsSARS-CoV-2Transplant Recipientsclinical research/practiceinfection and infectious agents - viralinfectious diseaseorgan transplantation in generalquality of care/care delivery

Identifiers

PMID34514710
PMCPMC8653312
OpenAlexW3200022755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.